Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07325253RecruitingPhase 2
PET scan to see graft-versus-host disease activity
This study tests a new PET imaging agent to see if it can show areas of graft-versus-host disease (GVHD) in the body. If it works, it might help doctors better understand and manage GVHD after a stem cell transplant.
Houston, TexasAges 18 years+ - NCT07329257Recruiting
Project PENGUIN: Study of rare brain development disorders
This study looks at rare and ultra-rare conditions that affect brain development. It aims to learn more about what causes these conditions. You may join if you or your child have a diagnosed or suspected neurogenetic disorder.
Columbia, MissouriAges Up to 99 years - NCT07332468Recruiting
Smartphone-based heart health program versus usual care
This study tests whether a digital remote management program (using a smartphone) helps people at high risk for heart disease or stroke make healthier lifestyle choices and better manage their medications, compared to usual care. It is for adults 35+ who are not already on advanced heart treatments.
BeijingAges 35 years+ - NCT07332988Enrolling by invitation
Light therapy for dry eyes in Graves' disease
This trial tests if low-level light therapy can improve dry eye symptoms in people with Graves' disease whose dry eyes haven't gotten better with standard treatments like artificial tears.
Iași, IaşiAges 18 years+ - NCT07330648RecruitingPhase 2
Crisugabalin for generalized anxiety disorder
This study tests a new investigational drug called crisugabalin for people with generalized anxiety disorder (GAD) who have not found enough relief from at least two other anxiety medications. The trial aims to see if crisugabalin can safely reduce anxiety symptoms.
Hefei, AnhuiAges 18 years+ - NCT07332260RecruitingPhase 1
Fecal transplant for Alzheimer's disease
This study tests whether a fecal transplant (transferring healthy bacteria from a donor's stool into your colon) can improve memory and thinking in people with mild to moderate Alzheimer's. You would receive the transplant via colonoscopy and have follow-up brain scans.
Tromsø, TromsAges 18 years+ - NCT07333677RecruitingEarly Phase 1
Testing CAR-T therapy for severe graves' disease
This early-phase trial tests a new type of treatment called CAR-T cells (special immune cells made in a lab) to target and calm down the overactive immune system in people with severe Graves' disease that hasn't improved with standard medicines. It may offer a new option for those who have been on treatment for years or have had multiple relapses.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05347069RecruitingPhase 4
Aspirin study for people with stable heart artery disease
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
KyotoAges 20 years+ - NCT05006859Recruiting
Wheelchair positioning for people with neuromuscular conditions
This trial looks at improving wheelchair positioning for people with neuromuscular diseases. Better positioning may help comfort, safety, and support day-to-day movement in a wheelchair.
AincourtAges 8 years+ - NCT03186391Recruiting
Exercise testing for leg artery disease symptoms
This study tests how well people with peripheral artery disease can use a treadmill for exercise testing. It may help doctors better understand exercise limits and guide safer care.
RennesAges 1.5 years+ - NCT06841471Recruiting
Role of Corneal Nerves in Dry Eye Disease
This study looks at how the nerves in the front of the eye (corneal nerves) relate to dry eye disease. It compares people with dry eye to those without to understand differences.
OltenAges 18 years+ - NCT07321925Recruiting
Using sound waves to measure liver fat
This study tests a new method that uses sound waves to measure fat in your liver. It could help doctors check liver health without a biopsy.
Ann Arbor, MichiganAges 18 years+ - NCT07322887RecruitingPhase 2
Study of sul-238 for early untreated parkinson's disease
This study tests whether an experimental medicine called SUL-238 can improve energy levels in the brain cells of people with early, untreated Parkinson's. It uses a special type of MRI to see if the medicine affects brain energy.
GroningenAges 40 years+ - NCT06869603Recruiting
Mediterranean diet for recurrent kidney stones and bone health
This trial looks at whether following the Mediterranean diet helps people who get kidney stones over and over again. It also checks how diet affects bone health. If you have had multiple kidney stones, you may be able to join.
NaplesAges 18 years+ - NCT06868875Recruiting
Small bowel MRI data sharing study
This study asks permission to use past MRI scans of your small bowel for research. It aims to improve how we understand and diagnose bowel conditions.
LondonAges 16 years+ - NCT07317297Recruiting
Shockwave therapy for Peyronie's disease
This trial tests whether sound waves (extracorporeal shockwave therapy) can help men with stable Peyronie's disease reduce curvature and plaque. It's for those whose condition hasn't changed for at least 6 months and who haven't had other treatments.
BakuAges 18–65 - NCT07322718RecruitingEarly Phase 1
Testing RXIM002 for severe autoimmune diseases
This study tests a new drug called RXIM002 for people with severe autoimmune diseases that haven't improved with standard treatments. It aims to see if targeting immune cells with the CD19 marker can help control the disease.
Shanghai, Huangpu DistrictAges 18–65 - NCT07316621Recruiting
Crohn's disease risk study for close relatives
This study follows close family members of people with Crohn's disease to see if they develop early signs of the condition. It uses blood tests and checkups to detect Crohn's earlier.
RomaAges 16–35 - NCT07324720Recruiting
Comparing ischemia vs plaque risk for high-risk artery disease
This trial compares two ways to decide which heart artery blockages need treatment: one looks at blood flow, the other at plaque buildup and risk. It's for people with high-risk blockages to see which approach leads to better outcomes.
Seoul, Main BuildingAges 19 years+ - NCT07323121Recruiting
Flickering light therapy for sleep problems in Parkinson's
This study tests whether a special flickering light (40 Hz) can help improve sleep in people with Parkinson's disease. Participants will be exposed to the light at home, and researchers will track changes in sleep quality.
Nanjing, JiangsuAges 50–75 - NCT07322939Recruiting
Exercise with visual feedback for Parkinson's
This trial tests whether adding visual feedback to exercise can help people with mild to moderate Parkinson's disease improve their movement and balance. It is designed for people who are only taking oral Parkinson's medications.
Gaziantep, ŞahinbeyAges 18–85 - NCT07324161Recruiting
Magnetic Brain Stimulation for Alzheimer's Disease
This trial tests whether a non-invasive magnetic brain stimulation treatment (TMS) can help people with mild to moderate Alzheimer's disease. You would receive the treatment and be monitored for safety and benefit.
Fuzhou, FujianAges 50–90 - NCT07321704Recruiting
Irrisept vs. Saline for Pilonidal Flap Surgery
This study compares two types of wound cleaning solutions used during surgery for pilonidal disease: an antiseptic called Irrisept (0.05% chlorhexidine gluconate) versus normal saline. The goal is to see if Irrisept helps prevent infection and improve healing after a flap-based closure procedure.
Los Angeles, CaliforniaAges 18 years+ - NCT07323927RecruitingEarly Phase 1
Testing galcanezumab for Alzheimer's disease
This trial tests whether galcanezumab, an antibody injection, can help people with mild-to-moderate Alzheimer's disease. It is for patients who have a confirmed Alzheimer's diagnosis and a caregiver who can support them.
BeijingAges 50–90
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,577 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.